Engineering immunocompetent 3D brain cultures for AAV-based gene therapy development

Authors

• Margarida Serra, iBET, Portugal
• Catarina Brito, iBET, Instituto de Biologia Experimental e Tecnológica, Portugal and Instituto de Tecnologia Química e Biológica António Xavier, Nova Universidade de Lisboa (ITQB NOVA), PortugalFollow
• Paula M Alves, iBET and ITQB NOVA
• Catarina M Gomes, iBET and ITQB NOVA
• Gabriela Silva, iBET and ITQB NOVA
• Mafalda Aleixo, iBET and ITQB NOVA
• Daniel Simão, iBET and ITQB NOVA
• Lekh N Dahal, University of Liverpool
• Stephan J Holtkamp, University of Liverpool
• Mark Trautwein, University of Liverpool
• Bayer Pradeep Harish, University of Liverpool

Conference Dates

February 1 – 5, 2026

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Margarida Serra, Catarina Brito, Paula M Alves, Catarina M Gomes, Gabriela Silva, Mafalda Aleixo, Daniel Simão, Lekh N Dahal, Stephan J Holtkamp, Mark Trautwein, and Bayer Pradeep Harish, "Engineering immunocompetent 3D brain cultures for AAV-based gene therapy development" in "Advancing Manufacture of Cell and Gene Therapies IX", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/22